Clinical trial
Restless Legs Patient Study On Absorption, Distribution, Metabolism And…
NCT00419692 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00419692 |
|---|---|
| Title | Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food |
| Official title | An Open Label, Repeat Dose, Dose Escalation Study Conducted in RLS Patients to Characterize Pharmacokinetics and Food Effect of Ropinirole Controlled Release for RLS |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Ropinirole |
| Enrollment | 32 |
| Start date | Aug 24, 2006 |
| Primary completion | Dec 12, 2006 |
| Completion | Dec 12, 2006 |
| First posted | Jan 9, 2007 |
| Last update posted | Oct 13, 2017 |
| Countries | Germany, South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: